JAK/STAT Signaling
Research Areas
Products Related to JAK/STAT Signaling(493)
- GC17473Pelitinib (EKB-569)CAS: 257933-82-7Purity: >98.00%
Pelitinib (EKB-569) (EKB-569;WAY-EKB 569) is an irreversible inhibitor of EGFR with an IC50 of 38.5 nM; also slightly inhibits Src, MEK/ERK and ErbB2 with IC50s of 282, 800, and 1255 nM, respectively.
- GC17647AG-18 (Tyrphostin 23)CAS: 118409-57-7Purity: >98.50%
AG-18 (Tyrphostin A23) is an EGFR inhibitor with an IC50 and Kiof 35 and 11 μM, respectively.
- GC10250Mubritinib (TAK 165)CAS: 366017-09-6Purity: >99.50%
Mubritinib (TAK 165) is a potent, selective inhibitor of HER2/ErbB2 with IC 50 of 6nM.
- GC10341Peficitinb (ASP015K, JNJ-54781532)CAS: 944118-01-8Purity: >98.00%
Peficitinb (ASP015K, JNJ-54781532) (ASP015K) is an orally active JAK inhibitor, with IC50s of 3.9, 5.0, 0.7 and 4.8 nM for JAK1, JAK2, JAK3 and Tyk2, respectively.
- GC10889ArtesunateCAS: 88495-63-0Purity: >98.00%
Artesunate is an antimalarial compound and an inhibitor of signal transducer and activator of transcription 3 (STAT-3) and membrane glutathione S-transferase (EXP1).
- GC11209Cerdulatinib (PRT062070)CAS: 1198300-79-6Purity: >99.50%
Cerdulatinib (PRT062070) (PRT062070) is a selective Tyk2 inhibitor with an IC50 of 0.5 nM. Cerdulatinib (PRT062070) (PRT062070) also is a dual JAK and SYK inhibitor with IC50s of 12, 6, 8 and 32 for JAK1, 2, 3 and SYK, respectively.
- GC12359HispidulinCAS: 1447-88-7Purity: >98.00%
Hispidulin is a flavonoid compound that acts as a Pim-1 inhibitor (IC₅₀=2.71μM).
- GC12578(R)-LisofyllineCAS: 100324-81-0Purity: >98.00%
(R)-Lisofylline is a small molecule compound with anti-inflammatory properties, acting as a lysophosphatidic acid acyltransferase inhibitor (IC₅₀ = 0.6μM).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC17473 | Pelitinib (EKB-569) | 257933-82-7 | >98.00% | |
Pelitinib (EKB-569) (EKB-569;WAY-EKB 569) is an irreversible inhibitor of EGFR with an IC50 of 38.5 nM; also slightly inhibits Src, MEK/ERK and ErbB2 with IC50s of 282, 800, and 1255 nM, respectively. | ||||
| GC17530 | OSI-420 | 183320-51-6 | >98.50% | |
OSI-420 (OSI-420) is an active metabolite of Erlotinib. Erlotinib is a potent EGFR tyrosin kinase inhibitor. | ||||
| GC17647 | AG-18 (Tyrphostin 23) | 118409-57-7 | >98.50% | |
AG-18 (Tyrphostin A23) is an EGFR inhibitor with an IC50 and Kiof 35 and 11 μM, respectively. | ||||
| GC17982 | Icotinib | 610798-31-7 | >98.00% | |
Icotinib is an epidermal growth factor receptor (EGFR; IC₅₀=5nM) inhibitor that targets mutants such as EGFR (L858R, T790M, L861Q). | ||||
| GC19408 | FM381 | 2226521-65-7 | >98.00% | |
FM-381 is a highly potent and JAK3-selective janus kinase (JAK) inhibitor | ||||
| GB62277 | iJak-381 | 1831144-46-7 | >97.00% | |
iJAK-381 is a novel, small-molecule inhibitor selectively targeting the Janus kinase (JAK) family, including JAK1, JAK2, JAK3 and TYK with IC 50 values of 8.52, 53.4, 5998 and 240nM respectively at 1mM ATP. | ||||
| GC10217 | RG-14620 | 136831-49-7 | >99.50% | |
inhibitor of epidermal growth factor (EGF) receptor kinase | ||||
| GC10250 | Mubritinib (TAK 165) | 366017-09-6 | >99.50% | |
Mubritinib (TAK 165) is a potent, selective inhibitor of HER2/ErbB2 with IC 50 of 6nM. | ||||
| GC10341 | Peficitinb (ASP015K, JNJ-54781532) | 944118-01-8 | >98.00% | |
Peficitinb (ASP015K, JNJ-54781532) (ASP015K) is an orally active JAK inhibitor, with IC50s of 3.9, 5.0, 0.7 and 4.8 nM for JAK1, JAK2, JAK3 and Tyk2, respectively. | ||||
| GC10439 | APTSTAT3-9R | - | >98% | |
STAT3 inhibitor | ||||
| GC10643 | Pimozide | 2062-78-4 | >98.00% | |
Pimozide is a chemically novel, highly potent and orally long-acting neuroleptic dopamine receptors inhibitor, with K i s of 2.4nM, 0.2nM and 1.8nM for dopamine D2, D3 and D4 receptors, respectively. | ||||
| GC10889 | Artesunate | 88495-63-0 | >98.00% | |
Artesunate is an antimalarial compound and an inhibitor of signal transducer and activator of transcription 3 (STAT-3) and membrane glutathione S-transferase (EXP1). | ||||
| GC11172 | TAK-285 | 871026-44-7 | >98.00% | |
HER2/EGFR(HER1) inhibitor | ||||
| GC11209 | Cerdulatinib (PRT062070) | 1198300-79-6 | >99.50% | |
Cerdulatinib (PRT062070) (PRT062070) is a selective Tyk2 inhibitor with an IC50 of 0.5 nM. Cerdulatinib (PRT062070) (PRT062070) also is a dual JAK and SYK inhibitor with IC50s of 12, 6, 8 and 32 for JAK1, 2, 3 and SYK, respectively. | ||||
| GC11264 | CNX-2006 | 1375465-09-0 | >99.50% | |
mutant-EGFR inhibitor, selective and irreversible | ||||
| GC11474 | Napabucasin | 83280-65-3 | >99.00% | |
STAT3 inhibitor | ||||
| GC11652 | CHZ868 | 1895895-38-1 | >99.00% | |
Type II JAK2 inhibitor | ||||
| GC11744 | AG 555 | 133550-34-2 | >98.00% | |
Potent EGFR-kinase inhibitor | ||||
| GC12038 | RG 13022 | 136831-48-6 | >98% | |
EGFR tyrosine kinase inhibitor | ||||
| GC12138 | 5,15-DPP | 22112-89-6 | >95.00% | |
5,15-DPP (5,15-DPP) is a selective STAT3-SH2 antagonist (IC50s of 0.28 μM and 10 μM for STAT3 and STAT1, respectively). | ||||
| GC12281 | EAI045 | 1942114-09-1 | >98.50% | |
Inhibitor of L858R/T790M EGFR mutants | ||||
| GC12359 | Hispidulin | 1447-88-7 | >98.00% | |
Hispidulin is a flavonoid compound that acts as a Pim-1 inhibitor (IC₅₀=2.71μM). | ||||
| GC12578 | (R)-Lisofylline | 100324-81-0 | >98.00% | |
(R)-Lisofylline is a small molecule compound with anti-inflammatory properties, acting as a lysophosphatidic acid acyltransferase inhibitor (IC₅₀ = 0.6μM). | ||||
| GC12712 | NT157 | 1384426-12-3 | >98% | |
NT157 is a selective inhibitor of insulin receptor substrate-1/-2 (IRS-1/2). | ||||
